Scarica l'app Stockscreener
26.14
3.51%
-0.94
Quidelortho Corporation Borsa (QDEL) Ultime notizie
Is QuidelOrtho's (QDEL) Steadfast Revenue Outlook a Sign of Management Conviction or Overconfidence? - simplywall.st
Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know - TradingView
QuidelOrtho launches certified analyzer program for rural healthcare - Investing.com
QuidelOrtho launches certified analyzer program for rural healthcare By Investing.com - Investing.com Nigeria
QuidelOrtho's Strategic Expansion in Point-of-Care Diagnostics: A Pathway to Long-Term Value Creation - AInvest
QuidelOrtho Launches Certified Analyzer Program | QDEL Stock News - GuruFocus
QuidelOrtho launches certified analyzer program for underserved areas - StreetInsider
QuidelOrtho Makes Premium Medical Testing More Affordable for Small Hospitals with Certified Analyzer Program - Stock Titan
The Top 5 Analyst Questions From QuidelOrtho’s Q2 Earnings Call - Yahoo Finance
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - Yahoo Finance
AI Tools Suggest QuidelOrtho Corporation May Outperform This WeekRisk Managed Intraday Trade Alerts Increase in Volume - 선데이타임즈
Earnings Release: Here's Why Analysts Cut Their QuidelOrtho Corporation (NASDAQ:QDEL) Price Target To US$43.14 - 富途牛牛
Published on: 2025-08-09 08:22:34 - beatles.ru
There's No Escaping QuidelOrtho Corporation's (NASDAQ:QDEL) Muted Revenues Despite A 29% Share Price Rise - 富途牛牛
Will QuidelOrtho's (QDEL) Renewed Cost Discipline Strengthen Its Long-Term Growth Story? - simplywall.st
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
QuidelOrtho narrows China outlook to mid-single-digit growth as cost actions drive margin gains - MSN
QuidelOrtho’s Earnings Call: Mixed Sentiment with Global Growth - The Globe and Mail
QuidelOrtho Topped Estimates But Still Posted A Net Loss - Finimize
QuidelOrtho (QDEL) Analyst Rating Update: UBS Lowers Price Target | QDEL Stock News - GuruFocus
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand - MSN
UBS Cuts Price Target on QuidelOrtho to $26 From $29, Maintains Neutral Rating - MarketScreener
Should Value Investors Buy QuidelOrtho (QDEL) Stock? - Yahoo Finance
QuidelOrtho 2025 Q2 Earnings Widens Losses Amid Revenue Decline - AInvest
QuidelOrtho Corporation (NASDAQ:QDEL) Q2 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho Q2 Revenue Beats Estimate, EPS Turns Positive Amid Restructuring Costs. - AInvest
QuidelOrtho Q2 2025 Earnings: Adjusted EPS Beats Estimates, Revenue Hits $614 Million - AInvest
Citigroup Reiterates Buy on QuidelOrtho, PT Lowered to $40 - AInvest
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats - AOL.com
QuidelOrtho shares rise 14.02% premarket after reporting Q2 earnings with improved EBITDA margin and cost savings. - AInvest
QuidelOrtho Stock Soars 10.85% on Q2 Earnings Beat - AInvest
Citi Adjusts QuidelOrtho (QDEL) Price Target, Maintains Buy Rati - GuruFocus
QuidelOrtho 2025 Q2 Earnings Deeper Losses Amid Revenue Decline - AInvest
QuidelOrtho revenue decreases to USD 614M in Q2 2025 - Medical Buyer
QuidelOrtho: Q2 Earnings Snapshot - Huron Daily Tribune
QuidelOrtho Corp SEC 10-Q Report - TradingView
QuidelOrtho's Q2 Financial Performance and Future OutlookNews and Statistics - IndexBox
QuidelOrtho's Strategic Cost-Cutting and Margin Expansion: A Hidden Opportunity in a Declining Revenue Environment? - AInvest
QuidelOrtho Fiscal Q2 Swings to Adjusted Earnings, Revenue Falls - MarketScreener
QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call Highlights: Naviga - GuruFocus
QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
QuidelOrtho's 2025 Q2 Earnings Call: Key Contradictions in COVID Revenue, Tariffs, and China Growth - AInvest
QuidelOrtho Corporation 2025 Q2ResultsEarnings Call Presentation (NASDAQ:QDEL) - Seeking Alpha
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats - The Motley Fool
QuidelOrtho Reports Q2 2025 Financial Results - TipRanks
QuidelOrtho Q2 2025 slides: EPS soars 271% despite revenue decline By Investing.com - Investing.com Nigeria
QuidelOrtho Q2 2025 slides: EPS soars 271% despite revenue decline - Investing.com
Earnings call transcript: Quidel Ortho’s Q2 2025 EPS beats forecast by 7900% - Investing.com Canada
QuidelOrtho’s (NASDAQ:QDEL) Q2 Earnings Results: Revenue In Line With Expectations, Stock Soars - TradingView
QuidelOrtho Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Quidel shares soar as Q2 results beat estimates, cost-saving initiatives pay off - Investing.com Nigeria
QuidelOrtho's Strategic Reimagining: A Deep Dive into Growth, Innovation, and Market Resilience - AInvest
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q2 Adjusted EPS $0.12 per Share, vs. FactSet Est of $0.00 - MarketScreener
Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q2 Revenue $613.9M, vs. FactSet Est of $611.1M - MarketScreener
QuidelOrtho Reports Second Quarter 2025 Financial Results - Yahoo Finance
QuidelOrtho shares rise 8.40% after-hours as Q2 revenue beats expectations. - AInvest
QuidelOrtho Corporation (QDEL): A Bull Case Theory - Insider Monkey
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):